Advanced search×

Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands

Gynecologic Oncology 106(1):142 (2007) PMID 17462723

Objectives To determine the risk for recurrent trophoblastic disease after spontaneous normalization of human chorionic gonadotropin (hCG) levels in patients with hydatidiform mole and to determine the risk for tumor relapse after apparent remission following chemotherapy in patients with low- and high-risk persistent trophoblastic disease.

DOI: 10.1016/j.ygyno.2007.03.010